about
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practiceTissue preparation for gene expression profiling of colorectal carcinoma: three alternatives to laser microdissection with preamplification.TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas.Comparability of microarray data between amplified and non amplified RNA in colorectal carcinoma.Non-compliance in surveillance for patients with previous resection of large (> or = 1 cm) colorectal adenomas.SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancerCommon denominator genes that distinguish colorectal carcinoma from normal mucosa.Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumours displaying either microsatellite stability (MSS) or instability (MSI).Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.[Chronic gout. Case report of a severe course of disease].The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).Treatment choice in EGFR-mutant non-small-cell lung cancer.Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.Initiation of CPAP therapy for OSA: does prophylactic humidification during CPAP pressure titration improve initial patient acceptance and comfort?Reproducibility of a standardized titration procedure for the initiation of continuous positive airway pressure therapy in patients with obstructive sleep apnoea.In vivo efficacy of heated and non-heated humidifiers during nasal continuous positive airway pressure (nCPAP)-therapy for obstructive sleep apnoea.Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma.T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis.[A case of attenuated familial adenomatous polyposis coli (AFAP)]Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma.Mismatch repair deficiency in sporadic synchronous colorectal cancerRight-sided shift found in metachronous colorectal adenomasPrognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine
P50
Q30664830-A867D986-9053-4D26-918B-3447649ABACEQ33203700-6CA531FA-2D5B-4AFE-804A-A30B36D4C322Q33293871-B0C36249-789F-48EB-9EBE-65EA8A695650Q33346209-68DDEEA9-E445-4BAF-8936-EA5C378A6011Q33510352-45C4E331-E44A-4A0C-9BDA-7FFF09FE0F09Q33866478-B4E07063-3D19-42F5-A49B-F1A2296F41F3Q35498689-8EFFF551-AA6F-4C92-B293-931B42336AC0Q35991464-1108E523-856E-4847-8B4F-8E9E21EEC042Q40423519-CB5A9682-C54C-41C7-9E8C-5491656AE1D3Q44487099-8552FDBD-2C0E-4757-8708-AB778FCEFE25Q44664508-193F60CF-7BED-4685-988F-03D8BC82E6A2Q46031627-9704015C-C982-4844-AD5E-98F1A540A378Q46069530-94789FE1-C257-4610-81BA-928B770F7366Q46720852-D1C35340-3BC4-4107-8018-D89F420C8E76Q47679976-4ECF6B83-F0F0-460F-AE48-CDD7EC240ED9Q47871569-1F145474-080C-43A0-962A-D865173FB577Q48314504-FEE489F3-AE64-4129-B484-E1FAA465DF5AQ48650737-C69CFF9C-8D9D-42FB-BCA8-EF397D9C001DQ48697418-B1801FAB-EAF3-4F2C-8752-B0D76CBE9D91Q48720318-FD06F741-5265-48B2-82C8-7042DA4FA130Q51072307-271FFAC1-7EEA-48E8-912A-074B050E4782Q51943523-39E4BE61-FEB9-4A4B-8606-BDC62366297FQ53272007-A7947A3D-63DA-4BF8-9F98-CC6BE98CCC6BQ53389868-A58941F2-8E2F-4678-B9B3-56776145B45CQ54483196-ECBDE920-41C8-4912-B4A3-2842EFAE480FQ54488979-71198976-7A54-4647-A2E1-BE9B4F402C53Q73505324-EFCD4D17-861C-4BE4-B25C-3956FFD482C3Q74266678-5B9416C0-B4D9-4494-95BD-C0F8DBF4A9A0Q75294868-4778E405-E31C-454F-B010-0923954E8EF2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wolfgang M Brueckl
@ast
Wolfgang M Brueckl
@en
Wolfgang M Brueckl
@es
Wolfgang M Brueckl
@nl
Wolfgang M Brueckl
@sl
type
label
Wolfgang M Brueckl
@ast
Wolfgang M Brueckl
@en
Wolfgang M Brueckl
@es
Wolfgang M Brueckl
@nl
Wolfgang M Brueckl
@sl
altLabel
Wolfgang Brueckl
@en
prefLabel
Wolfgang M Brueckl
@ast
Wolfgang M Brueckl
@en
Wolfgang M Brueckl
@es
Wolfgang M Brueckl
@nl
Wolfgang M Brueckl
@sl
P106
P21
P31
P496
0000-0002-7039-0791